| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PROS.10087 |
| P698 | PubMed publication ID | 11967953 |
| P50 | author | Jeffrey Trent | Q28033905 |
| William B Isaacs | Q89161930 | ||
| P2093 | author name string | Charles Ewing | |
| Jun Luo | |||
| Yidong Chen | |||
| Thomas Dunn | |||
| Jurga Sauvageot | |||
| P2860 | cites work | Inhibition of insulin receptor activation by insulin-like growth factor binding proteins | Q24310591 |
| Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II | Q24322395 | ||
| Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis | Q24551021 | ||
| Quantitative monitoring of gene expression patterns with a complementary DNA microarray | Q27861102 | ||
| Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search | Q28296089 | ||
| Thrombospondin-4 binds specifically to both collagenous and non-collagenous extracellular matrix proteins via its C-terminal domains | Q28564472 | ||
| Molecular classification of cutaneous malignant melanoma by gene expression profiling | Q29619204 | ||
| In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues | Q31825496 | ||
| Pieces of the puzzle: expressed sequence tags and the catalog of human genes | Q33368363 | ||
| New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia | Q33545598 | ||
| The insulin-like growth factor-binding protein superfamily | Q34030680 | ||
| Latent-TGF-beta: an overview | Q34251623 | ||
| The quiescin Q6 gene (QSCN6) is a fusion of two ancient gene families: thioredoxin and ERV1. | Q34486132 | ||
| Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells* | Q34585385 | ||
| Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I | Q36232491 | ||
| Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy | Q40398019 | ||
| Alpha 2-macroglobulin: a binding protein for transforming growth factor-beta and various cytokines | Q41268643 | ||
| Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma | Q42467495 | ||
| Normal histology of the prostate. | Q42489226 | ||
| Identification of genes differentially expressed in benign prostatic hyperplasia | Q42502870 | ||
| Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: relationship with binding proteins 2 and 3 and androgens | Q47997856 | ||
| Gene-Expression Profiles in Hereditary Breast Cancer | Q57240053 | ||
| Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer | Q58850537 | ||
| Increased expression of genes for basic fibroblast growth factor and transforming growth factor type beta 2 in human benign prostatic hyperplasia | Q67654333 | ||
| Histopathologic characterization of hereditary benign prostatic hyperplasia | Q71715035 | ||
| The development of human benign prostatic hyperplasia with age | Q72743475 | ||
| Enhanced expression of the mesenchymal marker, vimentin, in hyperplastic versus normal human prostatic epithelium | Q73944705 | ||
| Fibroblast growth factor receptor 1 (FGFR1) is over-expressed in benign prostatic hyperplasia whereas FGFR2-IIIc and FGFR3 are not | Q74410837 | ||
| Expression profiling using cDNA microarrays | Q77895878 | ||
| FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation | Q78015006 | ||
| Ratio-based decisions and the quantitative analysis of cDNA microarray images | Q87383035 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostatic hypertrophy | Q506659 |
| P304 | page(s) | 189-200 | |
| P577 | publication date | 2002-05-15 | |
| P1433 | published in | The Prostate | Q7758608 |
| P1476 | title | Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis | |
| P478 | volume | 51 |
| Q36932062 | 5,5'-Dibromo-bis(3'-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cells |
| Q37281184 | A signaling network in phenylephrine-induced benign prostatic hyperplasia |
| Q36918641 | A survey of commonalities relevant to function and dysfunction in pelvic and sexual organs |
| Q35551113 | Advantages and limitations of microarray technology in human cancer |
| Q83348681 | Age related changes of the extracellular matrix and stem cell maintenance |
| Q34507732 | Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression |
| Q33520245 | Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer |
| Q41653977 | Antrodan, a β-glucan obtained from Antrodia cinnamomea mycelia, is beneficial to benign prostate hyperplasia |
| Q28585269 | BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling |
| Q42103664 | BPH gene expression profile associated to prostate gland volume |
| Q38309500 | Bioinformatics approach leads to the discovery of the TMPRSS2:ETS gene fusion in prostate cancer |
| Q92704330 | Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients |
| Q38339706 | CONFAC: automated application of comparative genomic promoter analysis to DNA microarray datasets |
| Q33732687 | Cholesterol and benign prostate disease |
| Q42269970 | Developmental, cellular and molecular biology of benign prostatic hyperplasia |
| Q46761462 | Dynamic down-regulation of Krüppel-like factor 4 in colorectal adenoma-carcinoma sequence |
| Q49825766 | Effects of metformin on prostatic tissue of rats with metabolic syndrome and benign prostatic hyperplasia |
| Q33637491 | Estrogen receptor-related receptor alpha mediates up-regulation of aromatase expression by prostaglandin E2 in prostate stromal cells |
| Q37639586 | Etiology, epidemiology, and natural history of benign prostatic hyperplasia |
| Q37625720 | Etiopathogenesis of benign prostatic hypeprlasia |
| Q80217907 | Expression signatures that correlated with Gleason score and relapse in prostate cancer |
| Q36614769 | Extracellular influences on tumour angiogenesis in the aged host |
| Q24594253 | Gene expression profiling predicts clinical outcome of prostate cancer |
| Q92068023 | Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis |
| Q46930324 | Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men. |
| Q37258877 | Growth factors in benign prostatic hyperplasia: basic science implications |
| Q34770064 | High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression |
| Q28215702 | Identification and recombinant production of human laminin alpha4 subunit splice variants |
| Q41895631 | Impact of oral capsule of Peganum harmala on alleviating urinary symptoms in men with benign prostatic hyperplasia; a randomized clinical trial |
| Q42373538 | Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4. |
| Q47982349 | Increased and localized accumulation of chondroitin sulphate proteoglycans in the hyperplastic human prostate |
| Q81571865 | Increased expression of NKX3.1 in benign prostatic hyperplasia |
| Q37961164 | Influences of neuroregulatory factors on the development of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction in aging men. |
| Q36628945 | Kruppel-like factor 4 is a novel mediator of selenium in growth inhibition |
| Q24803332 | Mammographic density is related to stroma and stromal proteoglycan expression |
| Q91437039 | Mesenchymal stem cells and the embryonic reawakening theory of BPH |
| Q88208698 | Meta-analysis of vitamin D receptor gene polymorphisms and benign prostatic hyperplasia risk |
| Q31158946 | Microarray Data Mining for Potential Selenium Targets in Chemoprevention of Prostate Cancer |
| Q24528253 | Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer |
| Q38447424 | Molecular classification of benign prostatic hyperplasia: A gene expression profiling study in a rat model |
| Q35556012 | Molecular genetic aspects of prostate transition zone lesions |
| Q24649675 | Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity |
| Q37581408 | PDE5 inhibitors for LUTS. |
| Q34084593 | Personalized medicine for the management of benign prostatic hyperplasia |
| Q40713205 | Proteoglycan expression in normal human prostate tissue and prostate cancer. |
| Q37986399 | Proteoglycans in prostate cancer |
| Q36982102 | Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells |
| Q33397762 | Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate |
| Q37365172 | Subtypes of alpha1-adrenoceptors in BPH: future prospects for personalized medicine |
| Q37010408 | Systems biology and cancer stem cells |
| Q37573098 | TGF-beta3 and cancer: a review |
| Q92745233 | TWIST2: A new candidate tumor suppressor in prostate cancer |
| Q42702895 | The accumulation of versican in the nodules of benign prostatic hyperplasia |
| Q33493120 | The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasia |
| Q37209592 | The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms |
| Q33241082 | Transcriptomes of human prostate cells |
| Q42476964 | Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation |
| Q38881676 | Widespread telomere instability in prostatic lesions. |
Search more.